{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:45:11Z","timestamp":1793727911061,"version":"4.6.1"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.nut.2019.06.020","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T12:11:09Z","timestamp":1561723869000},"page":"110539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":200,"special_numbering":"C","title":["Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival"],"prefix":"10.1016","volume":"67-68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4330-9705","authenticated-orcid":false,"given":"Aoife M.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-3415","authenticated-orcid":false,"given":"Erin S.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek G.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2019.06.020_bib0001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1444-0903.2004.00518.x","article-title":"Malnutrition screening in hospitalised patients and its implication on reimbursement","volume":"34","author":"Raja","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.nut.2019.06.020_bib0002","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.clnu.2014.08.001","article-title":"Nutritional risk profile in a university hospital population","volume":"34","author":"Tangvik","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0003","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3945\/ajcn.115.126615","article-title":"Undernutrition screening survey in 564,063 patients: Patients with a positive undernutrition screening score stay in hospital 1.4 d longer","volume":"103","author":"Kruizenga","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0004","first-page":"279","article-title":"Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients","volume":"17","author":"Bozzetti","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0005","first-page":"491","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients","volume":"69","author":"Dewys","year":"1980","journal-title":"Eastern Cooperative Oncology Group. Am J Med"},{"key":"10.1016\/j.nut.2019.06.020_bib0006","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0007","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","article-title":"Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?","volume":"34","author":"Andreyev","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0008","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0009","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1111\/j.1572-0241.2007.01437.x","article-title":"Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer","volume":"102","author":"Di Fiore","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nut.2019.06.020_bib0010","first-page":"2625","article-title":"A systematic review of health-related quality of life instruments in patients with cancer cachexia","volume":"21","author":"Wheelwright","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0011","first-page":"1","article-title":"Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later","author":"Ryan","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.nut.2019.06.020_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0013","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","article-title":"Cachexia and sarcopenia: mechanisms and potential targets for intervention","volume":"2","author":"Argil\u00e9s","year":"2015","journal-title":"Curr Opin Pharmacol 2"},{"key":"10.1016\/j.nut.2019.06.020_bib0014","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0015","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0016","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/01635581.2015.1004728","article-title":"Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer","volume":"67","author":"Wesseltoft-Rao","year":"2015","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0017","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/cncr.22328","article-title":"Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation","volume":"107","author":"Krishnan","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0018","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/MPA.0000000000000590","article-title":"Weight Loss, diabetes, fatigue, and depression preceding pancreatic cancer","volume":"45","author":"Olson","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.nut.2019.06.020_bib0019","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/MPA.0000000000000898","article-title":"Predictors of pancreatic cancer-associated weight loss and nutritional interventions","volume":"46","author":"Nemer","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.nut.2019.06.020_bib0020","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","article-title":"Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer","volume":"34","author":"Blauwhoff-Buskermolen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0021","first-page":"1","article-title":"Cancer cachexia: identification by clinical assessment versus international consensus criteria in patients with metastatic colorectal cancer","author":"van der Werf","year":"2018","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0022","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.bjc.6605578","article-title":"Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres","volume":"102","author":"Pressoir","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0023","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.clnu.2008.03.002","article-title":"Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery?","volume":"27","author":"Pacelli","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0024","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clnu.2007.08.014","article-title":"Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer","volume":"26","author":"Correia","year":"2007","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/0884533617700862","article-title":"Handgrip strength is associated with treatment modifications during neoadjuvant chemoradiation in patients with esophageal cancer","volume":"32","author":"Lakenman","year":"2017","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.nut.2019.06.020_bib0026","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0027","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0028","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/annonc\/mdu501","article-title":"Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?","volume":"26","author":"Gioulbasanis","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0029","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1634\/theoncologist.2009-0283","article-title":"The diversity of nutritional status in cancer: new insights","volume":"15","author":"Ramos Chaves","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2019.06.020_bib0031","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jcsm.12258","article-title":"Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?","volume":"9","author":"N\u00ed Bhuachalla","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0032","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1055-9965.EPI-15-1336","article-title":"Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials","volume":"26","author":"Greenlee","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.nut.2019.06.020_bib0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/1055-9965.EPI-16-0150","article-title":"Postdiagnosis weight change and survival following a diagnosis of early-stage breast cancer","volume":"26","author":"Cespedes Feliciano","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.nut.2019.06.020_bib0034","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1245\/s10434-015-4429-z","article-title":"Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer","volume":"22","author":"van Vugt","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/bjc.2016.431","article-title":"The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma","volume":"116","author":"Daly","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0036","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0029665118000046","article-title":"A window beneath the skin: How computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes","volume":"77","author":"Daly","year":"2018","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.nut.2019.06.020_bib0037","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S0029665115004279","article-title":"Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact","volume":"75","author":"Prado","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.nut.2019.06.020_bib0038","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcsm.12267","article-title":"Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer","volume":"9","author":"Daly","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0039","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jcsm.12107","article-title":"Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients","volume":"7","author":"Rutten","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pmr.2011.11.012","article-title":"Aging of human muscle: understanding sarcopenia at the single muscle cell level","volume":"23","author":"Frontera","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.nut.2019.06.020_bib0041","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0042","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0043","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2015-0058","article-title":"Nutritional status, body surface, and low lean body mass\/body mass index are related to dose reduction and severe gastrointestinal toxicity induced by afatinib in patients with non-small cell lung cancer","volume":"20","author":"Arrieta","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2019.06.020_bib0044","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Stene","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0045","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/JTO.0000000000000690","article-title":"Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer","volume":"10","author":"Kim","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0046","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamasurg.2018.0979","article-title":"Association between changes in body composition and neoadjuvant treatment for pancreatic cancer","volume":"153","author":"Sandini","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0047","doi-asserted-by":"crossref","first-page":"e12076","DOI":"10.1097\/MD.0000000000012076","article-title":"Impact of sarcopenia on outcomes of patients undergoing pancreatectomy: a retrospective analysis of 107 patients","volume":"97","author":"El Amrani","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.nut.2019.06.020_bib0048","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0007114512001067","article-title":"Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia","volume":"109","author":"Di Sebastiano","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0049","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1245\/s10434-014-4285-2","article-title":"Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer","volume":"22","author":"Cooper","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0050","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clnu.2015.08.005","article-title":"The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma","volume":"35","author":"Rollins","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0051","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpainsymman.2011.09.010","article-title":"Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study","volume":"44","author":"Dalal","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.nut.2019.06.020_bib0052","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.clnu.2016.10.014","article-title":"Preoperative sarcopenia determinants in pancreatic cancer patients","volume":"36","author":"Carrara","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0053","first-page":"505","article-title":"The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma","volume":"21","author":"Thoresen","year":"2012","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.nut.2019.06.020_bib0054","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1245\/s10434-017-5829-z","article-title":"Prognostic value of computed tomography: measured parameters of body composition in primary operable gastrointestinal cancers","volume":"24","author":"Black","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0055","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11136-017-1539-z","article-title":"Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life","volume":"26","author":"van Roekel","year":"2017","journal-title":"Qual Life Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0056","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0057","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnu.2012.05.009","article-title":"Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results","volume":"32","author":"Thoresen","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0058","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1245\/s10434-016-5360-7","article-title":"Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer","volume":"23","author":"Chemama","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0059","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.clnu.2017.05.017","article-title":"The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer","volume":"37","author":"McSorley","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/SLA.0000000000000628","article-title":"Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery","volume":"261","author":"Reisinger","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0061","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jcsm.12337","article-title":"Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients","volume":"9","author":"Kurk","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0062","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ejso.2018.05.029","article-title":"Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer","volume":"44","author":"van Vugt","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0063","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clnesp.2018.01.003","article-title":"Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: a comparison with the malnutrition screening tool","volume":"24","author":"van der Kroft","year":"2018","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.nut.2019.06.020_bib0064","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jgo.2015.08.005","article-title":"Prevalence of sarcopenia in older patients with colorectal cancer","volume":"6","author":"Broughman","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00595-017-1564-0","article-title":"Sarcopenia is an independent predictor of complications after colorectal cancer surgery","volume":"48","author":"Nakanishi","year":"2018","journal-title":"Surg Today"},{"key":"10.1016\/j.nut.2019.06.020_bib0066","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/SLA.0000000000001113","article-title":"Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer","volume":"263","author":"Malietzis","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0067","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hpb.2016.11.009","article-title":"The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases","volume":"19","author":"Eriksson","year":"2017","journal-title":"HPB"},{"key":"10.1016\/j.nut.2019.06.020_bib0068","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer","volume":"66","author":"Barret","year":"2014","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0069","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12957-018-1327-4","article-title":"Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study","volume":"16","author":"J\u00e4rvinen","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0070","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/SLA.0000000000002398","article-title":"Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer","volume":"266","author":"Elliott","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0071","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00330-014-3110-4","article-title":"Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer","volume":"24","author":"Yip","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.nut.2019.06.020_bib0072","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clnu.2015.05.011","article-title":"Sarcopenic obesity: a probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients","volume":"35","author":"Anandavadivelan","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0073","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1007\/s00268-016-3603-1","article-title":"Sarcopenia\/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer","volume":"40","author":"Grotenhuis","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0074","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejso.2014.11.040","article-title":"Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer","volume":"41","author":"Tan","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0075","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1245\/s10434-015-4558-4","article-title":"Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery","volume":"22","author":"Reisinger","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0076","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clnu.2011.08.008","article-title":"Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer","volume":"31","author":"Awad","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0077","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejso.2016.11.015","article-title":"Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer","volume":"43","author":"Paireder","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0078","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00330-015-3963-1","article-title":"Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer","volume":"26","author":"Tamandl","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.nut.2019.06.020_bib0079","first-page":"603","article-title":"Impact of sarcopenia in patients with unresectable locally advanced esophageal cancer receiving chemoradiotherapy","volume":"32","author":"Sato","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/j.nut.2019.06.020_bib0080","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/jso.24214","article-title":"Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer","volume":"113","author":"Nishigori","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0081","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5230\/jgc.2017.17.e8","article-title":"Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer","volume":"17","author":"Palmela","year":"2017","journal-title":"J Gastric Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0082","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1245\/s10434-017-5811-9","article-title":"Prognostic significance of sarcopenia in patients with esophagogastric junction cancer or upper gastric cancer","volume":"24","author":"Kudou","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0083","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5230\/jgc.2018.18.e25","article-title":"Sarcopenia and post-operative morbidity and mortality in patients with gastric cancer","volume":"18","author":"O'Brien","year":"2018","journal-title":"J Gastric Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0084","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jso.24015","article-title":"Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes","volume":"112","author":"Tegels","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1245\/s10434-016-5385-y","article-title":"Impact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy","volume":"23","author":"Nishigori","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0086","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3892\/or.2015.4475","article-title":"Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer","volume":"35","author":"Hayashi","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nut.2019.06.020_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.01.011","article-title":"Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0088","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/COC.0000000000000061","article-title":"Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib","volume":"40","author":"Cushen","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0089","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.juro.2015.08.072","article-title":"Decreased skeletal muscle mass is associated with an increased risk of mortality after radical nephrectomy for localized renal cell cancer","volume":"195","author":"Psutka","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.nut.2019.06.020_bib0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/14737140.2013.866040","article-title":"Clinical implications of body composition assessment by computed tomography in metastatic renal cell carcinoma","volume":"14","author":"Antoun","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.nut.2019.06.020_bib0091","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.58","article-title":"Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients","volume":"108","author":"Huillard","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0092","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study","volume":"28","author":"Antoun","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0093","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.juro.2015.08.071","article-title":"Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma","volume":"195","author":"Fukushima","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.nut.2019.06.020_bib0094","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clgc.2017.01.022","article-title":"Prediction of everolimus toxicity and prognostic value of skeletal muscle index in patients with metastatic renal cell carcinoma","volume":"15","author":"Auclin","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0095","doi-asserted-by":"crossref","first-page":"e37563","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0096","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0097","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/SLA.0000000000000743","article-title":"sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma","volume":"261","author":"Voron","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0098","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/hepr.12562","article-title":"Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment","volume":"46","author":"Kamachi","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0099","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.dld.2015.07.001","article-title":"Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors","volume":"47","author":"Nault","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.nut.2019.06.020_bib0100","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1634\/theoncologist.2012-0169","article-title":"The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer","volume":"17","author":"Del Fabbro","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2019.06.020_bib0101","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0102","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/tbj.12952","article-title":"Beyond sarcopenia: characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population","volume":"24","author":"Weinberg","year":"2018","journal-title":"Breast J"},{"key":"10.1016\/j.nut.2019.06.020_bib0103","doi-asserted-by":"crossref","first-page":"25714","DOI":"10.18632\/oncotarget.25394","article-title":"Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines","volume":"9","author":"Mazzuca","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.nut.2019.06.020_bib0104","first-page":"861","article-title":"Impact of body composition on outcome in patients with early breast cancer","volume":"26","author":"Deluche","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","article-title":"Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.breast.2016.10.014","article-title":"Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy","volume":"31","author":"Rier","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.nut.2019.06.020_bib0107","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2016.05.027","article-title":"Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer","volume":"142","author":"Kumar","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0108","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1245\/s10434-018-6683-3","article-title":"Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery","volume":"25","author":"Ataseven","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0109","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-017-0464-x","article-title":"Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients","volume":"35","author":"Valentine","year":"2017","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.nut.2019.06.020_bib0110","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00345-018-2259-x","article-title":"Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer","volume":"36","author":"Mayr","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.nut.2019.06.020_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.12.004","article-title":"Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?","volume":"36","author":"Kocher","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0112","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1245\/s10434-016-5606-4","article-title":"Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy","volume":"23","author":"Hirasawa","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115895","article-title":"Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma","volume":"10","author":"Fukushima","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0114","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.28798","article-title":"Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer\u2013specific and all-cause mortality","volume":"120","author":"Psutka","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0115","first-page":"e39","article-title":"Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel","volume":"13","author":"Cushen","year":"2016","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.nut.2019.06.020_bib0116","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/j.clgc.2017.11.003","article-title":"The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy","volume":"16","author":"Mason","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0117","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hed.25420","article-title":"Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer","volume":"41","author":"Fattouh","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.nut.2019.06.020_bib0118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejh.12285","article-title":"Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"93","author":"Camus","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.nut.2019.06.020_bib0119","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/10428194.2013.816421","article-title":"Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"55","author":"Lanic","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.nut.2019.06.020_bib0120","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/ajh.24465","article-title":"Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy","volume":"91","author":"Xiao","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nut.2019.06.020_bib0121","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0122","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.ejca.2013.06.026","article-title":"Body composition and survival in the early clinical trials setting","volume":"49","author":"Veasey Rodrigues","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0123","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.nut.2019.06.020_bib0124","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.nut.2019.06.020_bib0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/01635581.2012.638433","article-title":"Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy","volume":"64","author":"Parsons","year":"2012","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0126","article-title":"Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value","volume":"24","author":"Srdic","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0127","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1634\/theoncologist.2017-0193","article-title":"Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer","volume":"23","author":"Versteeg","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2019.06.020_bib0128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11523-009-0108-y","article-title":"Maximum tolerated dose: Clinical endpoint for a bygone era?","volume":"4","author":"Takimoto","year":"2009","journal-title":"Target Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0129","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/jnci\/94.24.1883","article-title":"Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001","volume":"94","author":"Baker","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nut.2019.06.020_bib0130","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0959-8049(02)00151-X","article-title":"Sparreboom A Dosing strategies for anticancer drugs: The good, the bad and body-surface area","volume":"38","author":"Felici","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0131","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0132","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1139\/apnm-2013-0403","article-title":"The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer","volume":"39","author":"Prado","year":"2014","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.nut.2019.06.020_bib0133","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.cllc.2016.09.008","article-title":"Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer","volume":"18","author":"Sj\u00f8blom","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0134","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2015.07.001","article-title":"Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer","volume":"90","author":"Sj\u00f8blom","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0135","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1210\/jc.2013-1115","article-title":"Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: Results from a placebo-controlled study","volume":"98","author":"Massicotte","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nut.2019.06.020_bib0136","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00280-010-1288-y","article-title":"An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity","volume":"67","author":"Prado","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.nut.2019.06.020_bib0137","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1158\/1078-0432.CCR-16-2266","article-title":"Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0138","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cam4.621","article-title":"Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens","volume":"5","author":"Ali","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.nut.2019.06.020_bib0139","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1002\/cncr.30950","article-title":"Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study","volume":"23","author":"Cespedes Feliciano","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12371","article-title":"Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy","author":"Dijksterhuis","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0141","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pan.2018.11.001","article-title":"Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy","volume":"19","author":"Kurita","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.nut.2019.06.020_bib0142","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0143","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jcsm.12047","article-title":"Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib","volume":"6","author":"Moryoussef","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0144","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13539-013-0113-y","article-title":"A pilot study of temsirolimus and body composition","volume":"4","author":"Veasey-Rodrigues","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10637-013-0053-6","article-title":"Low skeletal muscle is associated with toxicity in patients included in phase I trials","volume":"32","author":"Cousin","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.nut.2019.06.020_bib0146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.05.012","article-title":"Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer","volume":"71","author":"Wendrich","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0147","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/PHM.0b013e31802ba53c","article-title":"Physiological basis of fatigue","volume":"86","author":"Evans","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"issue":"Suppl 1","key":"10.1016\/j.nut.2019.06.020_bib0148","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.12-S1-22","article-title":"Mechanisms of cancer-related fatigue","volume":"12","author":"Ryan","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2019.06.020_bib0149","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpainsymman.2011.03.013","article-title":"The effectiveness of patient-family carer intervention for the management of symptoms and other health-related problems in people affected by cancer: A systematic literature search and narrative review","volume":"43","author":"Hopkinson","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.nut.2019.06.020_bib0151","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jcsm.12199","article-title":"Muscle mass as a target to reduce fatigue in patients with advanced cancer","volume":"8","author":"Neefjes","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0152","article-title":"Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer","author":"Nipp","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2019.06.020_bib0153","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jcsm.12206","article-title":"Muscle mass and association to quality of life in non-small cell lung cancer patients","volume":"8","author":"Bye","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0154","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdu085","article-title":"Early recognition of malnutrition and cachexia in the cancer patient: A position paper of a European School of Oncology Task Force","volume":"25","author":"Aapro","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0155","first-page":"1","article-title":"Wright ORL Nutrition therapy for the management of cancer-related fatigue and quality of life: A systematic review and meta-analysis","author":"Baguley","year":"2018","journal-title":"Br J Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0156","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1158\/1078-0432.CCR-08-2584","article-title":"Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer","volume":"15","author":"Bower","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"Suppl","key":"10.1016\/j.nut.2019.06.020_bib0157","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.bbi.2012.06.011","article-title":"contributing factors, and treatment implications","volume":"30","author":"Bower","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nut.2019.06.020_bib0158","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cncr.28434","article-title":"Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors","volume":"120","author":"Wang","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/23809000.2017.1331705","article-title":"How and why systemic inflammation worsens quality of life in patients with advanced cancer","volume":"2","author":"McSorley","year":"2017","journal-title":"Expert review of quality of life in cancer care"},{"key":"10.1016\/j.nut.2019.06.020_bib0160","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response","volume":"34","author":"Laird","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0161","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djr556","article-title":"Oral nutritional interventions in malnourished patients with cancer: A systematic review and meta-analysis","volume":"104","author":"Baldwin","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nut.2019.06.020_bib0162","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.clnu.2017.07.010","article-title":"Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review","volume":"37","author":"Pamoukdjian","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0163","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0164","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","article-title":"Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes","volume":"54","author":"Kazemi-Bajestani","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.nut.2019.06.020_bib0165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ejcn.2015.32","article-title":"The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: A systematic review","volume":"69","author":"Gibson","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0166","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-17-0200","article-title":"Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study)","volume":"26","author":"Caan","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.nut.2019.06.020_bib0167","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0168","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.clnu.2016.03.010","article-title":"Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer","volume":"35","author":"Sj\u00f8blom","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0169","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1002\/cncr.31405","article-title":"Muscle radiodensity and mortality in patients with colorectal cancer","volume":"124","author":"Kroenke","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0170","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jcsm.12305","article-title":"The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: A population-based cohort study","volume":"9","author":"Brown","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0171","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00432-018-2736-z","article-title":"Low radiographic muscle density is associated with lower overall and disease-free survival in early-stage colorectal cancer patients","volume":"144","author":"van Baar","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0172","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2018.06.1326","article-title":"Comparison of the prognostic value of different skeletal muscle radiodensity parameters in endometrial cancer","author":"de Paula","year":"2018","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0173","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0174","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.28218","article-title":"Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies","volume":"119","author":"Antoun","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jcsm.12161","article-title":"Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy","volume":"8","author":"Chu","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0176","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1245\/s10434-016-5495-6","article-title":"Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer","volume":"24","author":"Van Rijssen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0177","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12885-019-5319-8","article-title":"Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: A post hoc analysis of two non-randomized phase II trials","volume":"19","author":"Charette","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0178","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/DCR.0000000000000958","article-title":"Impact of Low Muscularity and Myosteatosis on Long-term Outcome After Curative Colorectal Cancer Surgery: A Propensity Score-Matched Analysis","volume":"61","author":"Sueda","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.nut.2019.06.020_bib0179","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1245\/s10434-016-5668-3","article-title":"Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma","volume":"24","author":"Okumura","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0180","doi-asserted-by":"crossref","DOI":"10.1097\/DCR.0000000000001352","article-title":"The Impact of Muscle and Adipose Tissue on Long-Term Survival in Patients With Stage I to III Colorectal Cancer","author":"Hopkins","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.nut.2019.06.020_bib0181","article-title":"The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer","author":"Dolan","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0182","article-title":"Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases","author":"van Dijk","year":"2018","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0183","doi-asserted-by":"crossref","first-page":"e13363","DOI":"10.1097\/MD.0000000000013363","article-title":"Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy","volume":"97","author":"Park","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.nut.2019.06.020_bib0184","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2319","article-title":"Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer","volume":"3","author":"Cespedes Feliciano","year":"2017","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.nut.2019.06.020_bib0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/bjs.10075","article-title":"Influence of body composition profile on outcomes following colorectal cancer surgery","volume":"103","author":"Malietzis","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0186","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1245\/s10434-014-4281-6","article-title":"Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer","volume":"22","author":"Miyamoto","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0187","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bjs.7823","article-title":"Body composition and outcome in patients undergoing resection of colorectal liver metastases","volume":"99","author":"van Vledder","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.nut.2019.06.020_bib0188","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1245\/s10434-018-6354-4","article-title":"Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes","volume":"25","author":"Kuwada","year":"2018","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.nut.2019.06.020_bib0189","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/SLA.0000000000002252","article-title":"Assessment of Sarcopenia as a Predictor of Poor Outcomes after Esophagectomy in Elderly Patients with Esophageal Cancer","volume":"267","author":"Nakashima","year":"2018","journal-title":"Annals of surgery"},{"key":"10.1016\/j.nut.2019.06.020_bib0190","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1245\/s10434-018-6728-7","article-title":"Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer","volume":"25","author":"Nishigori","year":"2018","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.nut.2019.06.020_bib0191","article-title":"Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0192","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1245\/s10434-017-5813-7","article-title":"A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center","volume":"24","author":"Zheng","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0193","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.juro.2014.11.088","article-title":"Mortality after radical cystectomy: Impact of obesity versus adiposity after adjusting for skeletal muscle wasting","volume":"193","author":"Psutka","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.nut.2019.06.020_bib0194","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00277-018-3508-1","article-title":"Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia","volume":"98","author":"Nakamura","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.nut.2019.06.020_bib0195","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00277-015-2499-4","article-title":"Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma","volume":"94","author":"Nakamura","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.nut.2019.06.020_bib0196","article-title":"Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer","author":"Chargi","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.nut.2019.06.020_bib0197","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139749","article-title":"Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198812","article-title":"Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma","volume":"13","author":"Takada","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0199","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jcsm.12274","article-title":"Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer","volume":"9","author":"Choi","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5604\/16652681.1226821","article-title":"Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis","volume":"16","author":"Begini","year":"2017","journal-title":"Annals of hepatology"},{"key":"10.1016\/j.nut.2019.06.020_bib0201","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/hepr.12674","article-title":"Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma","volume":"46","author":"Harimoto","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.nut.2019.06.020_bib0202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.nut.2019.06.020_bib0203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jso.23976","article-title":"Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma","volume":"112","author":"Levolger","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0204","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1245\/s10434-014-3686-6","article-title":"Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma","volume":"21","author":"Itoh","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0205","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/1759-7714.12870","article-title":"Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy","volume":"9","author":"Cortellini","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.nut.2019.06.020_bib0206","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.21873\/anticanres.11372","article-title":"Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer","volume":"37","author":"Shoji","year":"2017","journal-title":"Anticancer research"},{"key":"10.1016\/j.nut.2019.06.020_bib0207","article-title":"Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study","author":"Zhang","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.06.020_bib0208","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12368","article-title":"The IMPACT study: Early loss of skeletal muscle mass in advanced pancreatic cancer patients","author":"Basile","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2019.06.020_bib0209","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1245\/s10434-018-6624-1","article-title":"Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial","volume":"25","author":"Park","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nut.2019.06.020_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169136","article-title":"Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients","volume":"12","author":"Nattenm\u00fcller","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195406","article-title":"Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"13","author":"Takeda","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0212","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129742","article-title":"Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer","volume":"10","author":"Miyamoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.06.020_bib0213","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: Rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial","volume":"8","author":"Solheim","year":"2018","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.nut.2019.06.020_bib0214","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jcsm.12379","article-title":"Caan BJ The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: Facts and numbers","volume":"9","author":"Brown","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900719300930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900719300930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:08:54Z","timestamp":1760270934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900719300930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":214,"alternative-id":["S0899900719300930"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2019.06.020","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2019.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110539"}}